Efficacy of Femarelle for the treatment of climacteric syndrome in postmenopausal women: An open label trial

doi:10.1016/j.tjog.2016.04.008

Chia Nan University of Pharmacy & Science Institutional Repository > 環境永續暨休閒學院 > 運動管理系 > 期刊論文 > Item 310902800/30972

jsp.display-item.identifier=請使用永久網址來引用或連結此文件: https://ir.cnu.edu.tw/handle/310902800/30972

標題:	Efficacy of Femarelle for the treatment of climacteric syndrome in postmenopausal women: An open label trial
作者:	Chen, Fang-Ping Chang, Chee Jen Chao, An-Shine Huang, Hong-Yuan Huang, Jian-Pei Wu, Meng-Hsing Tsai, Ching-Chou Kung, Fu-Tsai Chang, Ching-Wen Tsai, Yung-Chieh
貢獻者:	Chang Gung Mem Hosp, Dept Obstet & Gynecol Chang Gung Mem Hosp, Dept Obstet & Gynecol Chang Gung Mem Hosp, Dept Obstet & Gynecol Chang Gung Univ Chang Gung Univ, Clin Informat & Med Stat Res Ctr Mackay Mem Hosp, Dept Obstet & Gynecol Coll Med & Hosp, Dept Obstet & Gynecol Natl Cheng Kung Univ Taipei Med Univ Hosp, Dept Obstet & Gynecol Chi Mei Med Ctr Chia Nan Univ Pharm & Sci, Dept Sport Management
關鍵字:	climacteric syndrome Femarelle hot flushes postmenopausal women rats
日期:	2016-06
上傳時間:	2018-01-18 11:38:59 (UTC+8)
出版者:	Elsevier Taiwan
摘要:	Objective: To assess the effects of 2 months of treatment with Femarelle for climacteric syndrome in Taiwanese postmenopausal women. Materials and methods: A multi-center, open-label trial of 260 postmenopausal women, age >= 45 years with vasomotor symptoms. Women were enrolled after obtaining a detailed medical history and a thorough physical examination. They then received Femarelle (640 mg/d) twice daily for 8 weeks. The primary outcome was the changes in the frequency and severity of hot flushes from baseline to 4 weeks (1 month) and 8 weeks (2 months). Changes of general climacteric syndrome were assessed using a modified climacteric scale designed by Greene. Results: The frequency and severity of hot flushes were significantly improved with Femarelle use (p < 0.001). After 8 weeks of treatment, the percentage of women with various climacteric syndromes was reduced (from 100% to 20.9% for hot flushes, from 97.7% to 87.9% for psychological symptoms, from 93.8% to 78.8% for somatic symptoms, and from 87.8% to 74.9% for sexual symptoms). General climacteric syndrome scores also significantly decreased, from 20.8 +/- 0.7 at the time of enrollment to 12.9 +/- 0.7 after 8 weeks of Femarelle treatment (p < 0.0001). Participants experienced improvement of various climacteric symptoms and signs after 8 weeks of treatment (75.1% for hot flushes, 68.7% for psychological symptoms, 70.6% for somatic symptoms, and 69.0% for sexual problems respectively). After 4 weeks and 8 weeks of treatment with Femarelle, patients showed statistically significant improvement in climacteric symptoms (p < 0.0001). Three women (1.2%) withdrew from the study after 4 weeks of treatment due to adverse effects. Conclusion: Femarelle significantly improved climacteric symptoms in Taiwanese postmenopausal women. However, further evaluation is needed regarding the safety of long-term consumption. Copyright (C) 2016, Taiwan Association of Obstetrics & Gynecology. Published by Elsevier Taiwan LLC.
關聯:	Taiwanese Journal of Obstetrics & Gynecology, v.55 n.3, pp.336-340
显示于类别:	[運動管理系] 期刊論文

文件中的档案:

档案	描述	大小	格式	浏览次数
30972.pdf		414Kb	Adobe PDF	0	检视/开启
index.html		0Kb	HTML	1751	检视/开启

在CNU IR中所有的数据项都受到原著作权保护.

TAIR相关文章

数据加载中.....